HOME >> BIOLOGY >> NEWS
Healthy coral reefs hit hard by warmer temperatures

Coral disease outbreaks have struck the healthiest sections of Australia's Great Barrier Reef, where for the first time researchers have conclusively linked disease severity and ocean temperature. Close living quarters among coral may make it easy for infection to spread, researchers have found.

"With this study, speculation about the impacts of global warming on the spread of infectious diseases among susceptible marine species has been brought to an end," said Don Rice, director of the National Science Foundation (NSF) Chemical Oceanography Program, which funded the research through the joint NSF-National Institutes of Health Ecology of Infectious Diseases Program.

For 6 years, the international research team, led by University of North Carolina (UNC)-Chapel Hill, tracked an infection called white syndrome in 48 reefs along more than 900 miles (1,500 kilometers) of Australia's coastline.

The colorful coral colonies that attract visitors to the Great Barrier Reef live atop a limestone scaffolding built from the calcium carbonate secretions of each tiny coral, or polyp. While polyps provide the framework, coral's vivid hues come from symbiotic single-celled algae that live in the polyps. The algae supply much of the food coral need to survive.

When disease or stressful environmental conditions strike a coral colony, the polyps expel their algae. This algae loss makes the coral appear pale.

"We're left with a big question. Can corals and other marine species successfully adapt or evolve, when faced with such change?" Rice said.

Understanding the causes of disease outbreaks will help ecologists protect reef-building corals, which support commercial marine species and buffer low-lying coastal areas.

"More diseases are infecting more coral species every year, leading to the global loss of reef-building corals and the decline of other important species dependent on reefs," said lead study author Jo
'"/>

Contact: Cheryl Dybas
cdybas@nsf.gov
703-292-7734
National Science Foundation
7-May-2007


Page: 1 2

Related biology news :

1. Healthy reefs hit hardest by warmer temperatures
2. Healthy coastal wetlands would adapt to rising oceans
3. Second graders dig into Healthy Choices, Healthy Me!
4. Healthy coral reefs of Madagascar resisting damage from climate change
5. Healthy fruits, vegetables highlight joint medical, agricultural research meet in Texas
6. Healthy cleavage: How statins protect against Alzheimer disease
7. Healthy mix of GI tract microbes are key to preventing allergies and asthma
8. Indo-Pacific coral reefs disappearing more rapidly than expected
9. Departure to cold water corals and other hot spots
10. Investigating coral reefs to help understand past and future climate change
11. Palaus coral reefs show differential habitat recovery following the 1998 bleaching event

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Healthy coral reefs hit hard warmer temperatures

(Date:8/12/2015)... SAN JOSE, Calif. , Aug. 12, 2015 ... leading developer of human interface solutions, today announced ... the recently announced Match-in-Sensor solution, have officially been ... (FIDO) Alliance. As part of the certification, Synaptics, ... the FIDO 1.0 Universal Authentication Framework (UAF) standard ...
(Date:8/6/2015)... BOSTON and TELTOW, Germany ... the 2015 Siggraph Conference, SensoMotoric Instruments (SMI) ... augmented reality , based on Epson,s Moverio ... eye tracking platform. With this new solution, unprecedented quality ... multi-modal, hands-free interaction with context-sensitive displays. For the first ...
(Date:8/4/2015)... Research and ... addition of the "Digital Forensics Market ... (Computer Forensics, Network Forensics, Mobile Device Forensics, ... and Region - Global Forecast to 2020" ... By Component (Hardware, Software, and Service), Sub-Segment ...
Breaking Biology News(10 mins):Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2
(Date:8/28/2015)... , Aug. 28, 2015 /PRNewswire/ - RepliCel ... stage regenerative medicine company focused on the development ... for the quarter ended June 30, 2015, corporate ... and management report are available at www.sedar.com ... . "RepliCel expects to launch ...
(Date:8/28/2015)... ... ... the initial launch of FireflySci Inc. (FFS) in early 2015, the company continues to shake ... as the Fonz in a lab coat and Large Marge have been posted on the ... , FireflySci is proud to be the only cuvette manufacturer is the world that ...
(Date:8/27/2015)... Reston, VA (PRWEB) , ... August 27, 2015 , ... ... government contractors solve complex business problems, is pleased to announce their ranking as one ... 34th annual ranking of the fastest-growing private companies across the nation. , “It is ...
(Date:8/27/2015)... 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC ... Pharmaceutical Holding Company Limited (Biohaven), announced today that ... of BHV-0223, a glutamate modulating agent. Biohaven filed ... recently obtained clearance from the U.S. Food and ... Portage holds 54% equity interest in Biohaven, a ...
Breaking Biology Technology:RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5Cuvette Manufacturer FireflySci Launches Back to School Deals with Complimentary Shipping On All Orders 2Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 2Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4
Cached News: